BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2547314)

  • 1. Inhibition of adenylate kinase by P1,P5-di(adenosine 5') pentaphosphate in assays of erythrocyte enzyme activities requiring adenine nucleotides.
    Valentine WN; Paglia DE; Nakatani M; Brockway RA
    Am J Hematol; 1989 Oct; 32(2):143-5. PubMed ID: 2547314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P1,P5-Di(adenosine-5')pentaphosphate(Ap5A) as an inhibitor of adenylate kinase in studies of fragmented sarcoplasmic reticulum from bullfrog skeletal muscle.
    Kurebayashi N; Kodama T; Ogawa Y
    J Biochem; 1980 Sep; 88(3):871-6. PubMed ID: 6252207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the complex of adenylate kinase from Escherichia coli with the inhibitor P1,P5-di(adenosine-5'-)pentaphosphate.
    Müller CW; Schulz GE
    J Mol Biol; 1988 Aug; 202(4):909-12. PubMed ID: 2845103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies on the inhibition of glycolytic kinases of human erythrocytes by 2,3-diphosphoglyceric acid.
    Ponce J; Roth S; Harkness DR
    Biochim Biophys Acta; 1971 Oct; 250(1):63-74. PubMed ID: 4258865
    [No Abstract]   [Full Text] [Related]  

  • 5. Does an inhibitor of mitochondrial adenylate kinase also affect oxidative phosphorylation?
    Lüstorff J; Schlimme E
    Experientia; 1976 Mar; 32(3):298-9. PubMed ID: 176055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of mitochondrial oxidative phosphorylation: selective inhibition of adenylate kinase activity by P1,P5-di-(adenosine-5')-pentaphosphate.
    Melnick RL; Rubenstein CP; Motzkin SM
    Anal Biochem; 1979 Jul; 96(1):7-11. PubMed ID: 227290
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure of the complex of yeast adenylate kinase with the inhibitor P1,P5-di(adenosine-5'-)pentaphosphate at 2.6 A resolution.
    Egner U; Tomasselli AG; Schulz GE
    J Mol Biol; 1987 Jun; 195(3):649-58. PubMed ID: 2821281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aberrant adenylate kinase isoenzyme from the serum of patients with Duchenne muscular dystrophy.
    Hamada M; Okuda H; Oka K; Watanabe T; Ueda K; Nojima M; Kuby SA; Manship M; Tyler FH; Ziter FA
    Biochim Biophys Acta; 1981 Aug; 660(2):227-37. PubMed ID: 6269633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P1, P5-Bis-(5'-adenosyl)pentaphosphate: is this adenylate kinase inhibitor substrate for mitochondrial processes?
    Köhrle J; Lüstorff J; Schlimme E
    Z Naturforsch C Biosci; 1977; 32(9-10):786-91. PubMed ID: 201118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of adenylate kinase by P1-(lin-benzo-5'-adenosyl)-P4-(5'-adenosyl) tetraphosphate and P1-(lin-benzo-5'-adenosyl)-P5-(5'-adenosyl pentaphosphate.
    VanDerLijn P; Barrio JR; Leonard NJ
    Biochemistry; 1979 Dec; 18(25):5557-61. PubMed ID: 229895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative inhibition of human adenylate kinase and creatine kinase isoenzymes by adenosine 5'-monophosphate and diadenosine pentaphosphate.
    Nealon DA
    Clin Chem; 1985 Feb; 31(2):333-4. PubMed ID: 2981647
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protein structure and enzyme activity. 3. Suppressibility by pyridoxal-5-phosphate of glucose-6-phosphate dehydrogenase and other enzymes of carbohydrate metabolism].
    Domschke W; Domagk GF
    Hoppe Seylers Z Physiol Chem; 1969 Sep; 350(9):1111-6. PubMed ID: 4242507
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of adenylate kinase activity on the rate and efficiency of energy transport from mitochondria to hexokinase.
    Dzeja P; Kalvenas A; Toleikis A; Praskevicius A
    Biochem Int; 1985 Feb; 10(2):259-65. PubMed ID: 2986636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic inhibitors of adenylate kinases in the assays for ATPases and phosphokinases.
    Feldhau P; Fröhlich T; Goody RS; Isakov M; Schirmer RH
    Eur J Biochem; 1975 Sep; 57(1):197-204. PubMed ID: 170110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified method for the determination of phosphoribosylpyrophosphate synthetase activity in hemolysates.
    Torres RJ; Mateos FA; Puig JG; Becker MA
    Clin Chim Acta; 1994 Jan; 224(1):55-63. PubMed ID: 8174278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specificity of chromium nucleotides as inhibitors of selected kinases.
    Janson CA; Cleland WW
    J Biol Chem; 1974 Apr; 249(8):2572-4. PubMed ID: 4362688
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity of yeast glycolytic enzymes to chloroquine.
    Manhart A; Kalisz H; Holzer H
    Arch Microbiol; 1988; 150(3):309-12. PubMed ID: 2845878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle adenylate kinase in Duchenne muscular dystrophy.
    Fröhlich T; Reitter B; Scheffner D; Schirmer RH; Untucht-Grau R
    Biochim Biophys Acta; 1986 Oct; 883(3):598-603. PubMed ID: 3019420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythrocyte enzyme changes in hemophilia A].
    Barretto OC; Pinheiro ED; Nonoyama K
    Rev Paul Med; 1985; 103(1):44-5. PubMed ID: 2994200
    [No Abstract]   [Full Text] [Related]  

  • 20. General and kinetic properties of pig heart mitochondrial adenylate kinase.
    Font B; Gautheron DC
    Biochim Biophys Acta; 1980 Feb; 611(2):299-308. PubMed ID: 6243987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.